NVDA vs TCRX · P/E 58, rev $215.94B vs rev $2.0M
NVIDIA Corporation (NVDA) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jen-Hsun Huang.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported NVDA revenue for 2026-01-25 was $215.94B. Net income was $120.07B. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
NVDA currently screens at market cap $4.40T and trailing P/E 58.2. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the NVDA and TCRX stock pages for the full models.
Not investment advice.